Market Place
Sourcing Support
Vivani Medical Reports $5M Financing & Q3 2024 Results
13 Nov 2024 //
BUSINESSWIRE
Vivani Medical To Present At PODD Event And ThinkEquity Conference
22 Oct 2024 //
BUSINESSWIRE
Vivani Gets Approval For GLP-1 Implant Trial In Australia
26 Sep 2024 //
BUSINESSWIRE
Vivani Medical To Present At Emerging Growth Conference
23 Sep 2024 //
BUSINESSWIRE
Vivani Medical Announces Positive Preclinical Liver Fat Results GLP-1 Implant
04 Sep 2024 //
BUSINESSWIRE
Vivani Medical To Participate In H.C. Wainwright Conference
28 Aug 2024 //
BUSINESSWIRE
Vivani Medical Reports Q2 2024 Results And Business Update
13 Aug 2024 //
BUSINESSWIRE
Vivani Medical Updates On Long-Term GLP-1 Obesity Implant Program
11 Jul 2024 //
BUSINESSWIRE
Vivani Gets FDA IND Clearance, Clinical Hold Lifted For GLP-1 Implant NPM-119
13 Jun 2024 //
BUSINESSWIRE
Vivani Medical: Positive Veterinary Weight Loss Data For GLP-1 Implant
28 May 2024 //
BUSINESSWIRE
Vivani Medical Provides Update, Reports Q1 2024 Results
13 May 2024 //
BUSINESSWIRE
Vivani Medical to Present at TIDES Conference 2024
09 May 2024 //
BUSINESSWIRE
Vivani Provides Business Update and Reports Q4 and FY23 Financial Results
26 Mar 2024 //
BUSINESSWIRE
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
06 Mar 2024 //
BUSINESSWIRE
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering
01 Mar 2024 //
BUSINESSWIRE
Vivani`s exenatide implant boosts weight loss as well as Wegovy
01 Mar 2024 //
FIERCE BIOTECH
Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data
28 Feb 2024 //
BUSINESSWIRE
Vivani Provides Business Update and Reports Third Quarter Financial Results
14 Nov 2023 //
BUSINESSWIRE
Vivani Medical to Present at BIO Investor Forum
16 Oct 2023 //
BUSINESSWIRE
Vivani Medical to Present at the Boulder Peptide Symposium
07 Sep 2023 //
BUSINESSWIRE
Cortigent to Present Study Results at The Eye & The Chip World Research Congress
05 Sep 2023 //
BUSINESSWIRE
Vivani Reports Second Quarter Financial Results and Provides Business Update
14 Aug 2023 //
BUSINESSWIRE
Vivani Medical to Participate in Panel Discussion at the Healthcare Conference
14 Jun 2023 //
BUSINESSWIRE
Vivani Medical Reports First Quarter Financial & Provides Business Update
15 May 2023 //
BUSINESSWIRE
Vivani Announces $1M NIH Grant Funding to Support Cortigent’s Orion Study
04 Apr 2023 //
BUSINESSWIRE
Vivani Medical Reports 4Q & 2022 Financial Results and Provides Business Update
31 Mar 2023 //
BUSINESSWIRE
Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates
14 Nov 2022 //
BUSINESSWIRE
Vivani Medical to Present at the ThinkEquity Investor Conference
17 Oct 2022 //
BUSINESSWIRE
Second Sight Mergers with Nano Precision & its Name Change to Vivani Medical
30 Aug 2022 //
BUSINESSWIRE
Second Sight Medical Products Announces Shareholder Approval for Proposed Merger
29 Jul 2022 //
BUSINESSWIRE
